Petco Narrows Loss to $2.58M, Hints at Profitability Turn

Petco Health (WOOF) reported fiscal 2026 Q4 earnings on March 11, 2026, with revenue declining 2.4% to $1.52 billion but narrowing its net loss by 81.4% year-over-year. The company’s guidance for 2026 reflects flat to 1.5% net sales growth, aligning with its focus on profitability and operational efficiency.

Revenue

Petco Health’s total revenue for Q4 2026 fell to $1.52 billion, a 2.4% decrease from $1.55 billion in Q4 2025. Product sales accounted for the lion’s share of revenue at $1.26 billion, while services and other segments contributed $255.90 million. The decline reflects strategic shifts toward higher-margin offerings and store closures.

Earnings/Net Income

The company significantly narrowed its losses, reporting a net loss of $2.58 million in Q4 2026 compared to $13.84 million in Q4 2025. Earnings per share improved from a loss of $0.05 to $0.01, signaling progress toward profitability amid cost discipline and margin expansion. This marked improvement underscores Petco’s operational turnaround.

Price Action

Shares of Petco Health edged up 1.69% in the latest trading day but faced broader pressure, dropping 4.00% weekly and 8.40% month-to-date. The stock’s volatility highlights market skepticism about near-term recovery despite earnings progress.

Post-Earnings Price Action Review

The strategy of buying Petco shares after revenue outperformed expectations and holding for 30 days has historically delivered strong returns. Over three years, the approach generated an 86.67% cumulative gain, outpacing the S&P 500’s 42.86%. Notable gains followed the Q1 2024 and Q4 2025 earnings reports, with the March 11, 2026, release driving a 13.33% surge. A 30-day hold period typically extended momentum, as seen after the Q1 2024 earnings, while risk management minimized losses during market downturns.

CEO Commentary

Joel Anderson emphasized Petco’s 2025 progress, including a 21% rise in adjusted EBITDA and 77% higher operating cash flow. He outlined 2026 priorities: product innovation, scaled services, store experience enhancements, and an integrated omnichannel model. The CEO highlighted a shift from defensive to offensive strategies, focusing on profitability and customer retention.

Guidance

CFO Sabrina Simmons provided 2026 guidance: Q1 net sales down 1% to flat, with Adjusted EBITDA of $92M–$94M. For the full year, net sales are expected to grow flat to +1.5%, with 15–20 net store closures. Adjusted EBITDA is projected at $415M–$430M, alongside free cash flow improvements and disciplined capital allocation.

Additional News

Petco Health priced $600 million in senior secured notes in early 2026 to strengthen its capital structure. The company also announced a loyalty program relaunch and cross-selling initiatives to boost customer retention. Leadership changes, including new hires in key roles, were highlighted as part of its 2026 transformation strategy.